Arthur Rosenbaum is a New York, New York based male podiatrist who is specialized in Podiatry. Active license number of Arthur Rosenbaum for Podiatry is P2443 in New York. Arthur Rosenbaum is qualified with a Doctor of Podiatric Medicine (D.P.M.) degree, licensed by the state, and practicing within the scope of that license. He diagnose and treat foot diseases and deformities. He can perform medical, surgical and other operative procedures, prescribe corrective devices and prescribe and administer drugs and physical therapy.
Complete Profile:
Arthur Rosenbaum speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Podiatrist
Credentials:
DPM
Gender:
Male
Practice Address:
26 Broadway, Suite 739, New York, New York, 10004
Phone:
212-480-1983
Fax:
718-258-0683
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1366528598
NPI Enumeration Date:
31 Oct, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Arthur Rosenbaum are as mentioned below.
License Number
Specialization
State
Status
P2443
Podiatry
New York
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1088 E 22nd Street, Brooklyn, New York
Zip:
11210
Phone Number:
212-480-1983
Fax Number:
718-258-0683
Patients can reach Arthur Rosenbaum at 26 Broadway, Suite 739, New York, New York or can call to book an appointment on 212-480-1983. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.